Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.12 EUR | +0.16% | -9.53% | -7.83% |
05-22 | Nanobiotix: strategy update, share price declines | CF |
05-21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.83% | 313M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Transcript : Nanobiotix S.A., 2022 Earnings Call, Apr 25, 2023